Shuangshuang Lu

197 Ruijin Second Road
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Associations of TILs and Genomic Alterations in HER2+ Early Breast Cancer.

Associations of TILs and Genomic Alterations in HER2+ Early Breast Cancer.

Journal: Endocrine-related cancer

Published: October 15, 2025

Integrating genomic mutations and tumor-infiltrating lymphocytes improves prediction of response to trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer.

Integrating genomic mutations and tumor-infiltrating lymphocytes improves prediction of response to trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer.

Journal: Cancer drug resistance (Alhambra, Calif.)

Published: July 03, 2025

PABPC3 drives ovarian cancer metastasis and drug sensitivity by downregulating CLDN1 expression.

PABPC3 drives ovarian cancer metastasis and drug sensitivity by downregulating CLDN1 expression.

Journal: Cell death & disease

Published: November 12, 2024

The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial.

The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial.

Journal: Cancers

Published: June 01, 2022

Axilla lymph node dissection can be safely omitted in patients with 1-2 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis.

Axilla lymph node dissection can be safely omitted in patients with 1-2 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis.

Journal: Breast cancer research and treatment

Published: April 13, 2022

A novel metabolic gene signature-based nomogram to predict overall survival in breast cancer.

A novel metabolic gene signature-based nomogram to predict overall survival in breast cancer.

Journal: Annals of translational medicine

Published: April 12, 2021

Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer.

Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer.

Journal: Breast (Edinburgh, Scotland)

Published: January 26, 2021

Identification of Ten Mitosis Genes Associated with Tamoxifen Resistance in Breast Cancer.

Identification of Ten Mitosis Genes Associated with Tamoxifen Resistance in Breast Cancer.

Journal: OncoTargets and therapy

Published: November 24, 2020

Subdivision of M1 Stage for De Novo Metastatic Breast Cancer to Better Predict Prognosis and Response to Primary Tumor Surgery.

Subdivision of M1 Stage for De Novo Metastatic Breast Cancer to Better Predict Prognosis and Response to Primary Tumor Surgery.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: November 03, 2018

The impact of surgical excision of the primary tumor in stage IV breast cancer on survival: a meta-analysis.

The impact of surgical excision of the primary tumor in stage IV breast cancer on survival: a meta-analysis.

Journal: Oncotarget

Published: March 01, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026